Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells

Yao-Borengasser,Aiwei; Monzavi-Karbassi,Behjatolah; Hedges,Rebecca A.; Rogers,Lora J.; Kadlubar,Susan A.; Kieber-Emmons,Thomas

doi:10.3892/or.2015.3880

Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells

Authors:
- Aiwei Yao-Borengasser
- Behjatolah Monzavi-Karbassi
- Rebecca A. Hedges
- Lora J. Rogers
- Susan A. Kadlubar
- Thomas Kieber-Emmons
View Affiliations

Affiliations: Division of Medical Genetics, College of Medicine, and Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA, Department of Pathology, College of Medicine, and Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
Published online on: March 30, 2015 https://doi.org/10.3892/or.2015.3880
Pages: 2689-2694
Copyright: © Yao-Borengasser et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The development of breast cancer is linked to the loss of estrogen receptor (ER) during the course of tumor progression, resulting in loss of responsiveness to hormonal treatment. The mechanisms underlying dynamic ERα gene expression change in breast cancer remain unclear. A range of physiological and biological changes, including increased adipose tissue hypoxia, accompanies obesity. Hypoxia in adipocytes can establish a pro-malignancy environment in breast tissues. Epidemiological studies have linked obesity with basal-like breast cancer risk and poor disease outcome, suggesting that obesity may affect the tumor phenotype by skewing the microenvironment toward support of more aggressive tumor phenotypes. In the present study, human SGBS adipocytes were co-cultured with ER-positive MCF7 cells for 24 h. After co-culture, HIF1α, TGF-β, and lectin-type oxidized LDL receptor 1 (LOX1) mRNA levels in the SGBS cells were increased. Expression levels of the epithelial-mesenchymal transition (EMT)-inducing transcription factors FOXC2 and TWIST1 were increased in the co-cultured MCF7 cells. In addition, the E-cadherin mRNA level was decreased, while the N-cadherin mRNA level was increased in the co-cultured MCF7 cells. ERα mRNA levels were significantly repressed in the co-cultured MCF7 cells. ERα gene expression in the MCF7 cells was decreased due to increased HIF1α in the SGBS cells. These results suggest that adipocytes can modify breast cancer cell ER gene expression through hypoxia and also can promote EMT processes in breast cancer cells, supporting an important role of obesity in aggressive breast cancer development.

View Figures

View References

1	Powers GL, Ellison-Zelski SJ, Casa AJ, Lee AV and Alarid ET: Proteasome inhibition represses ERalpha gene expression in ER⁺ cells: a new link between proteasome activity and estrogen signaling in breast cancer. Oncogene. 29:1509–1518. 2010. View Article : Google Scholar :
2	Fox EM, Davis RJ and Shupnik MA: ERbeta in breast cancer - onlooker, passive player, or active protector? Steroids. 73:1039–1051. 2008. View Article : Google Scholar : PubMed/NCBI
3	Fowler AM and Alarid ET: Amping up estrogen receptors in breast cancer. Breast Cancer Res. 9:3052007. View Article : Google Scholar : PubMed/NCBI
4	Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 320:479–484. 1989. View Article : Google Scholar : PubMed/NCBI
5	Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV, Wei SH, Davuluri RV, Plass C, et al: Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res. 64:8184–8192. 2004. View Article : Google Scholar : PubMed/NCBI
6	Ryu K, Park C and Lee Y: Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells. Biochem Biophys Res Commun. 407:831–836. 2011. View Article : Google Scholar : PubMed/NCBI
7	Kurebayashi J, Otsuki T, Moriya T and Sonoo H: Hypoxia reduces hormone responsiveness of human breast cancer cells. Jpn J Cancer Res. 92:1093–1101. 2001. View Article : Google Scholar : PubMed/NCBI
8	Stoner M, Saville B, Wormke M, Dean D, Burghardt R and Safe S: Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Mol Endocrinol. 16:2231–2242. 2002. View Article : Google Scholar : PubMed/NCBI
9	Yi JM, Kwon HY, Cho JY and Lee YJ: Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner. Biochem Biophys Res Commun. 378:842–846. 2009. View Article : Google Scholar
10	Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, et al: Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 56:901–911. 2007. View Article : Google Scholar : PubMed/NCBI
11	Rausch ME, Weisberg S, Vardhana P and Tortoriello DV: Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes. 32:451–463. 2008. View Article : Google Scholar
12	Chung S, Yoon IY, Shin YK, Lee CH, Kim JW, Lee T, Choi DJ and Ahn HJ: Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep. 30:997–1001. 2007.PubMed/NCBI
13	Ye J, Gao Z, Yin J and He Q: Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab. 293:E1118–E1128. 2007. View Article : Google Scholar : PubMed/NCBI
14	Wojtczak L and Schönfeld P: Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta. 1183:41–57. 1993. View Article : Google Scholar : PubMed/NCBI
15	Fridlyand LE and Philipson LH: Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes Metab. 8:136–145. 2006. View Article : Google Scholar : PubMed/NCBI
16	Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, et al: Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 109:123–139. 2008. View Article : Google Scholar :
17	Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K, Wolff R, Murtaugh M, Baumgartner R, Giuliano A and Byers T: Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat. 102:85–101. 2007. View Article : Google Scholar
18	Maiti B, Kundranda MN, Spiro TP and Daw HA: The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat. 121:479–483. 2010. View Article : Google Scholar
19	Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al: Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 71:2455–2465. 2011. View Article : Google Scholar : PubMed/NCBI
20	Wabitsch M, Brenner RE, Melzner I, Braun M, Möller P, Heinze E, Debatin KM and Hauner H: Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord. 25:8–15. 2001. View Article : Google Scholar : PubMed/NCBI
21	Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B, Nolen GT, Kern EM, Nagarajan R, Spencer HJ III, Lee MJ, et al: Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes. 57:432–439. 2008. View Article : Google Scholar
22	Cooney CA, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ, Ferrone S, Kieber-Emmons T, et al: Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res. 13:R582011. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J and Gleadle JM: Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem. 281:15215–15226. 2006. View Article : Google Scholar : PubMed/NCBI
25	Dirat B, Bochet L, Escourrou G, Valet P and Muller C: Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? Endocr Dev. 19:45–52. 2010. View Article : Google Scholar : PubMed/NCBI
26	Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN and Cristofanilli M: Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res. 14:1718–1725. 2008. View Article : Google Scholar : PubMed/NCBI
27	McTiernan A, Irwin M and Vongruenigen V: Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol. 28:4074–4080. 2010. View Article : Google Scholar : PubMed/NCBI
28	Creighton CJ, Sada YH, Zhang Y, Tsimelzon A, Wong H, Dave B, Landis MD, Bear HD, Rodriguez A and Chang JC: A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat. 132:993–1000. 2012. View Article : Google Scholar
29	Xu J, Lamouille S and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
30	Liang M, Zhang P and Fu J: Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett. 258:31–37. 2007. View Article : Google Scholar : PubMed/NCBI
31	Wang R, Ding G, Liang W, Chen C and Yang H: Role of LOX-1 and ROS in oxidized low-density lipoprotein induced epithelial-mesenchymal transition of NRK52E. Lipids Health Dis. 9:1202010. View Article : Google Scholar : PubMed/NCBI
32	Sánchez-Elsner T, Ramírez JR, Sanz-Rodriguez F, Varela E, Bernabéu C and Botella LM: A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads. J Mol Biol. 336:9–24. 2004. View Article : Google Scholar : PubMed/NCBI
33	Chen HC, Zhu YT, Chen SY and Tseng SC: Selective activation of p120ctn-Kaiso signaling to unlock contact inhibition of ARPE-19 cells without epithelial-mesenchymal transition. PLoS One. 7:e368642012. View Article : Google Scholar : PubMed/NCBI
34	Goel HL and Mercurio AM: VEGF targets the tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
35	van Uden P, Kenneth NS and Rocha S: Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J. 412:477–484. 2008. View Article : Google Scholar : PubMed/NCBI